94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Sarah Ingrid Pinto Santos1*
Santiago José Ortiz-Peñuela2
Alessandro de Paula Filho1
Ana Laura Midori Rossi Tomiyama2
Lilian de Oliveira Coser2
Juliano Coelho da Silveira1
Daniele dos Santos Martins1
Adriano Polican Ciena3
Alexandre Leite Rodrigues de Oliveira2
Carlos Eduardo Ambrósio1- 1Faculty of Animal Science and Food Engineering, University of São Paulo (FZEA/USP), São Paulo, Brazil
- 2Institute of Biology, University of Campinas (IB/UNICAMP), Campinas, Brazil
- 3Institute of Biosciences, São Paulo State University, Rio Claro, Brazil
A corrigendum on
Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation
Santos, S. I. P., Ortiz-Peñuela, S. J., de Paula Filho, A., Tomiyama, A. L. M. R., Coser, L. d. O., da Silveira, J. C., Martins, D. d. S., Ciena, A. P., de Oliveira, A. L. R., and Ambrósio, C. E. (2024). Front. Cell. Neurosci. 18:1413843. doi: 10.3389/fncel.2024.1413843
In the published article, there was an error in the Funding statement. In the Funding statement for the São Paulo Research Foundation, only grant 2021/09869–6 was displayed. The correct statement is São Paulo Research Foundation grant 2021/09869–6 and grant 2022/10604-0. The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by São Paulo Research Foundation (FAPESP) under grant numbers 2021/09869-6 and 2022/10604-0, and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES (Brazil) - funding code 001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: extracellular vesicles, multiple sclerosis, neural stem cell, neurodegeneration, immunomodulation, oligodendrocyte precursor cell
Citation: Santos SIP, Ortiz-Peñuela SJ, de Paula Filho A, Tomiyama ALMR, Coser LdO, da Silveira JC, Martins DdS, Ciena AP, de Oliveira ALR and Ambrósio CE (2025) Corrigendum: Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation. Front. Cell. Neurosci. 18:1546979. doi: 10.3389/fncel.2024.1546979
Received: 17 December 2024; Accepted: 18 December 2024;
Published: 07 January 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Santos, Ortiz-Peñuela, de Paula Filho, Tomiyama, Coser, da Silveira, Martins, Ciena, de Oliveira and Ambrósio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sarah Ingrid Pinto Santos, c2FyYWhpbmdyaWRwc2FudG9zQGdtYWlsLmNvbQ==